Panome Bio Introduces Innovative Exposomics Services to Advance Health Research Panome Bio has launched an exposomics platform, offering groundbreaking chemical exposure profiling services essential for disease research.

Panome Bio Introduces Innovative Exposomics Services to Advance Health Research #USA #St._Louis #Panome_Bio #Exposomics #Chemical_Exposure

Panome Bio Launches MassID™: Revolutionary Tool for Metabolomics Analysis Panome Bio unveils MassID™, a transformative platform enhancing metabolomics data analysis, paving the way for significant biotech advancements.

Panome Bio Launches MassID™: Revolutionary Tool for Metabolomics Analysis #USA #St._Louis #Metabolomics #Panome_Bio #MassID™

Revolutionizing Clinical Research: Panome Bio's Innovative Metabolomics Workflow for FFPE Samples Panome Bio has introduced a groundbreaking metabolomics workflow for FFPE samples, enhancing clinical discovery and transforming data analysis in research.

Revolutionizing Clinical Research: Panome Bio's Innovative Metabolomics Workflow for FFPE Samples #USA #St._Louis #Metabolomics #Panome_Bio #FFPE_Samples

Panome Bio Receives CLIA Certification, Elevating Clinical Laboratory Standards Panome Bio has successfully obtained CLIA certification for its advanced laboratory, enhancing its capabilities in clinical laboratory testing and multi-omics services.

Panome Bio Receives CLIA Certification, Elevating Clinical Laboratory Standards #United_States #St._Louis #CLIA_Certification #multi-omics #Panome_Bio

Panome Bio Enhances Multi-Omic Services with New Transcriptomics Offering Panome Bio, renowned for its multi-omic services, introduces transcriptomics to its suite, enhancing biological analysis for researchers.

Panome Bio Enhances Multi-Omic Services with New Transcriptomics Offering #United_States #St._Louis #Transcriptomics #Panome_Bio #biomarker_discovery

Panome Bio Unveils New Global Phosphoproteomics Platform Enhancing Multi-Omic Research Panome Bio introduces a global phosphoproteomics platform, revolutionizing multi-omic discovery solutions and advancing disease research.

Panome Bio Unveils New Global Phosphoproteomics Platform Enhancing Multi-Omic Research #United_States #St._Louis #multi-omics #Panome_Bio #phosphoproteomics

Panome Bio Expands Leadership with Jean-Pierre Wery as New Board Member Ahead of 2025 Growth Panome Bio has appointed Jean-Pierre Wery to its Board of Directors, setting the stage for significant growth in 2025 as the company expands its operations.

Panome Bio Expands Leadership with Jean-Pierre Wery as New Board Member Ahead of 2025 Growth #United_States #St._Louis #biotechnology #Panome_Bio #Jean-Pierre_Wery